Accurate Classification of Metastatic Brain Tumors Using a Novel MicroRNA-Based Test

The validity of a recently developed microRNA-based quantitative reverse transcriptase polymerase chain reaction test for identifying the tumor tissue of origin, first in a consecutive cohort of metastatic tumors of known origin and then in a cohort of cancer of unknown primary cases resected from the central nervous system, was evaluated